Global Infectious Disease Biomarker Testing Market Growth (Status and Outlook) 2021-2027
According to this latest study, the 2021 growth of Infectious Disease Biomarker Testing will have significant change from previous year. By the most conservative estimates of global Infectious Disease Biomarker Testing market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the Infectious Disease Biomarker Testing market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2027.
This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Biomarker Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2027 in section 10.7.
PCR
NGS
ELISA or EIA
IHC
ISH
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2027 in section 10.8.
Hospitals and Clinics
Diagnostic Centers
Academic Research Institutes
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abacus Diagnostica
ALPCO
Abbott Laboratories
Agilent Technologies
Becton
Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche
Hologic
PerkinElmer
Qiagen
Quest Diagnostics Incorporated
Siemens Healthineers
Thermo Fisher Scientific
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Infectious Disease Biomarker Testing Market Size 2016-2026
2.1.2 Infectious Disease Biomarker Testing Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Infectious Disease Biomarker Testing Segment by Type
2.2.1 PCR
2.2.2 PCR
2.2.3 ELISA or EIA
2.2.4 IHC
2.2.5 ISH
2.2.6 Others
2.3 Infectious Disease Biomarker Testing Market Size by Type
2.3.1 Global Infectious Disease Biomarker Testing Market Size CAGR by Type
2.3.2 Global Infectious Disease Biomarker Testing Market Size Market Share by Type (2016-2021)
2.4 Infectious Disease Biomarker Testing Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Diagnostic Centers
2.4.3 Academic Research Institutes
2.4.4 Others
2.5 Infectious Disease Biomarker Testing Market Size by Application
2.5.1 Global Infectious Disease Biomarker Testing Market Size CAGR by Application
2.5.2 Global Infectious Disease Biomarker Testing Market Size Market Share by Application (2016-2021)
3 Infectious Disease Biomarker Testing Market Size by Players
3.1 Infectious Disease Biomarker Testing Market Size Market Share by Players
3.1.1 Global Infectious Disease Biomarker Testing Revenue by Players (2019-2021E)
3.1.2 Global Infectious Disease Biomarker Testing Revenue Market Share by Players (2019-2021E)
3.2 Global Infectious Disease Biomarker Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Infectious Disease Biomarker Testing by Regions
4.1 Infectious Disease Biomarker Testing Market Size by Regions (2016-2021)
4.2 Americas Infectious Disease Biomarker Testing Market Size Growth (2016-2021)
4.3 APAC Infectious Disease Biomarker Testing Market Size Growth (2016-2021)
4.4 Europe Infectious Disease Biomarker Testing Market Size Growth (2016-2021)
4.5 Middle East & Africa Infectious Disease Biomarker Testing Market Size Growth (2016-2021)
5 Americas
5.1 Americas Infectious Disease Biomarker Testing Market Size by Country (2016-2021)
5.2 Americas Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
5.3 Americas Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Disease Biomarker Testing Market Size by Region (2016-2021)
6.2 APAC Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
6.3 APAC Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Infectious Disease Biomarker Testing by Country (2016-2021)
7.2 Europe Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
7.3 Europe Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Infectious Disease Biomarker Testing by Region (2016-2021)
8.2 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2016-2021)
8.3 Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Infectious Disease Biomarker Testing Market Forecast
10.1 Global Infectious Disease Biomarker Testing Forecast by Regions (2021-2026)
10.1.1 Global Infectious Disease Biomarker Testing Forecast by Regions (2021-2026)
10.1.2 Americas Infectious Disease Biomarker Testing Forecast
10.1.3 APAC Infectious Disease Biomarker Testing Forecast
10.1.4 Europe Infectious Disease Biomarker Testing Forecast
10.1.5 Middle East & Africa Infectious Disease Biomarker Testing Forecast
10.2 Americas Infectious Disease Biomarker Testing Forecast by Countries (2021-2026)
10.2.1 United States Infectious Disease Biomarker Testing Market Forecast
10.2.2 Canada Infectious Disease Biomarker Testing Market Forecast
10.2.3 Mexico Infectious Disease Biomarker Testing Market Forecast
10.2.4 Brazil Infectious Disease Biomarker Testing Market Forecast
10.3 APAC Infectious Disease Biomarker Testing Forecast by Region (2021-2026)
10.3.1 China Infectious Disease Biomarker Testing Market Forecast
10.3.2 Japan Infectious Disease Biomarker Testing Market Forecast
10.3.3 Korea Infectious Disease Biomarker Testing Market Forecast
10.3.4 Southeast Asia Infectious Disease Biomarker Testing Market Forecast
10.3.5 India Infectious Disease Biomarker Testing Market Forecast
10.3.6 Australia Infectious Disease Biomarker Testing Market Forecast
10.4 Europe Infectious Disease Biomarker Testing Forecast by Country (2021-2026)
10.4.1 Germany Infectious Disease Biomarker Testing Market Forecast
10.4.2 France Infectious Disease Biomarker Testing Market Forecast
10.4.3 UK Infectious Disease Biomarker Testing Market Forecast
10.4.4 Italy Infectious Disease Biomarker Testing Market Forecast
10.4.5 Russia Infectious Disease Biomarker Testing Market Forecast
10.5 Middle East & Africa Infectious Disease Biomarker Testing Forecast by Region (2021-2026)
10.5.1 Egypt Infectious Disease Biomarker Testing Market Forecast
10.5.2 South Africa Infectious Disease Biomarker Testing Market Forecast
10.5.3 Israel Infectious Disease Biomarker Testing Market Forecast
10.5.4 Turkey Infectious Disease Biomarker Testing Market Forecast
10.5.5 GCC Countries Infectious Disease Biomarker Testing Market Forecast
10.6 Global Infectious Disease Biomarker Testing Forecast by Type (2021-2026)
10.7 Global Infectious Disease Biomarker Testing Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Abacus Diagnostica
11.1.1 Abacus Diagnostica Company Information
11.1.2 Abacus Diagnostica Infectious Disease Biomarker Testing Product Offered
11.1.3 Abacus Diagnostica Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Abacus Diagnostica Main Business Overview
11.1.5 Abacus Diagnostica Latest Developments
11.2 ALPCO
11.2.1 ALPCO Company Information
11.2.2 ALPCO Infectious Disease Biomarker Testing Product Offered
11.2.3 ALPCO Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 ALPCO Main Business Overview
11.2.5 ALPCO Latest Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Information
11.3.2 Abbott Laboratories Infectious Disease Biomarker Testing Product Offered
11.3.3 Abbott Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Abbott Laboratories Main Business Overview
11.3.5 Abbott Laboratories Latest Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Information
11.4.2 Agilent Technologies Infectious Disease Biomarker Testing Product Offered
11.4.3 Agilent Technologies Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Agilent Technologies Main Business Overview
11.4.5 Agilent Technologies Latest Developments
11.5 Becton
11.5.1 Becton Company Information
11.5.2 Becton Infectious Disease Biomarker Testing Product Offered
11.5.3 Becton Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Becton Main Business Overview
11.5.5 Becton Latest Developments
11.6 Dickinson and Company
11.6.1 Dickinson and Company Company Information
11.6.2 Dickinson and Company Infectious Disease Biomarker Testing Product Offered
11.6.3 Dickinson and Company Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Dickinson and Company Main Business Overview
11.6.5 Dickinson and Company Latest Developments
11.7 bioMérieux SA
11.7.1 bioMérieux SA Company Information
11.7.2 bioMérieux SA Infectious Disease Biomarker Testing Product Offered
11.7.3 bioMérieux SA Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 bioMérieux SA Main Business Overview
11.7.5 bioMérieux SA Latest Developments
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Information
11.8.2 Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Offered
11.8.3 Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Bio-Rad Laboratories Main Business Overview
11.8.5 Bio-Rad Laboratories Latest Developments
11.9 Danaher
11.9.1 Danaher Company Information
11.9.2 Danaher Infectious Disease Biomarker Testing Product Offered
11.9.3 Danaher Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Danaher Main Business Overview
11.9.5 Danaher Latest Developments
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Information
11.10.2 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Offered
11.10.3 F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 F. Hoffmann-La Roche Main Business Overview
11.10.5 F. Hoffmann-La Roche Latest Developments
11. Hologic
11.11.1 Hologic Company Information
11.11.2 Hologic Infectious Disease Biomarker Testing Product Offered
11.11.3 Hologic Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Hologic Main Business Overview
11.11.5 Hologic Latest Developments
11.12 PerkinElmer
11.12.1 PerkinElmer Company Information
11.12.2 PerkinElmer Infectious Disease Biomarker Testing Product Offered
11.12.3 PerkinElmer Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 PerkinElmer Main Business Overview
11.12.5 PerkinElmer Latest Developments
11.13 Qiagen
11.13.1 Qiagen Company Information
11.13.2 Qiagen Infectious Disease Biomarker Testing Product Offered
11.13.3 Qiagen Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Qiagen Main Business Overview
11.13.5 Qiagen Latest Developments
11.14 Quest Diagnostics Incorporated
11.14.1 Quest Diagnostics Incorporated Company Information
11.14.2 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Offered
11.14.3 Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Quest Diagnostics Incorporated Main Business Overview
11.14.5 Quest Diagnostics Incorporated Latest Developments
11.15 Siemens Healthineers
11.15.1 Siemens Healthineers Company Information
11.15.2 Siemens Healthineers Infectious Disease Biomarker Testing Product Offered
11.15.3 Siemens Healthineers Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Siemens Healthineers Main Business Overview
11.15.5 Siemens Healthineers Latest Developments
11.16 Thermo Fisher Scientific
11.16.1 Thermo Fisher Scientific Company Information
11.16.2 Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Offered
11.16.3 Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Thermo Fisher Scientific Main Business Overview
11.16.5 Thermo Fisher Scientific Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Infectious Disease Biomarker Testing Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of PCR
Table 3. Major Players of NGS
Table 4. Major Players of ELISA or EIA
Table 5. Major Players of IHC
Table 6. Major Players of ISH
Table 7. Major Players of Others
Table 8. Infectious Disease Biomarker Testing Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 9. Global Infectious Disease Biomarker Testing Market Size by Type (2016-2021) & ($ Millions)
Table 10. Global Infectious Disease Biomarker Testing Market Size Market Share by Type (2016-2021)
Table 11. Infectious Disease Biomarker Testing Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 12. Global Infectious Disease Biomarker Testing Market Size by Application (2016-2021) & ($ Millions)
Table 13. Global Infectious Disease Biomarker Testing Market Size Market Share by Application (2016-2021)
Table 14. Global Infectious Disease Biomarker Testing Revenue by Players (2019-2021E) & ($ Millions)
Table 15. Global Infectious Disease Biomarker Testing Revenue Market Share by Players (2019-2021E)
Table 16. Infectious Disease Biomarker Testing Key Players Head office and Products Offered
Table 17. Infectious Disease Biomarker Testing Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Infectious Disease Biomarker Testing Market Size by Regions 2016-2021 & ($ Millions)
Table 21. Global Infectious Disease Biomarker Testing Market Size Market Share by Regions 2016-2021
Table 22. Americas Infectious Disease Biomarker Testing Market Size by Country (2016-2021) & ($ Millions)
Table 23. Americas Infectious Disease Biomarker Testing Market Size Market Share by Country (2016-2021)
Table 24. Americas Infectious Disease Biomarker Testing Market Size by Type (2016-2021) & ($ Millions)
Table 25. Americas Infectious Disease Biomarker Testing Market Size Market Share by Type (2016-2021)
Table 26. Americas Infectious Disease Biomarker Testing Market Size by Application (2016-2021) & ($ Millions)
Table 27. Americas Infectious Disease Biomarker Testing Market Size Market Share by Application (2016-2021)
Table 28. APAC Infectious Disease Biomarker Testing Market Size by Region (2016-2021) & ($ Millions)
Table 29. APAC Infectious Disease Biomarker Testing Market Size Market Share by Region (2016-2021)
Table 30. APAC Infectious Disease Biomarker Testing Market Size by Type (2016-2021) & ($ Millions)
Table 31. APAC Infectious Disease Biomarker Testing Market Size Market Share by Type (2016-2021)
Table 32. APAC Infectious Disease Biomarker Testing Market Size by Application (2016-2021) & ($ Millions)
Table 33. APAC Infectious Disease Biomarker Testing Market Size Market Share by Application (2016-2021)
Table 34. Europe Infectious Disease Biomarker Testing Market Size by Country (2016-2021) & ($ Millions)
Table 35. Europe Infectious Disease Biomarker Testing Market Size Market Share by Country (2016-2021)
Table 36. Europe Infectious Disease Biomarker Testing Market Size by Type (2016-2021) & ($ Millions)
Table 37. Europe Infectious Disease Biomarker Testing Market Size Market Share by Type (2016-2021)
Table 38. Europe Infectious Disease Biomarker Testing Market Size by Application (2016-2021) & ($ Millions)
Table 39. Europe Infectious Disease Biomarker Testing Market Size Market Share by Application (2016-2021)
Table 40. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Region (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Infectious Disease Biomarker Testing Market Size Market Share by Region (2016-2021)
Table 42. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Type (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Infectious Disease Biomarker Testing Market Size Market Share by Type (2016-2021)
Table 44. Middle East & Africa Infectious Disease Biomarker Testing Market Size by Application (2016-2021) & ($ Millions)
Table 45. Middle East & Africa Infectious Disease Biomarker Testing Market Size Market Share by Application (2016-2021)
Table 46. Key and Potential Regions of Infectious Disease Biomarker Testing
Table 47. Key Application and Potential Industries of Infectious Disease Biomarker Testing
Table 48. Key Challenges of Infectious Disease Biomarker Testing
Table 49. Key Trends of Infectious Disease Biomarker Testing
Table 50. Global Infectious Disease Biomarker Testing Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 51. Global Infectious Disease Biomarker Testing Market Size Market Share Forecast by Regions (2021-2026)
Table 52. Global Infectious Disease Biomarker Testing Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 53. Global Infectious Disease Biomarker Testing Market Size Market Share Forecast by Type (2021-2026)
Table 54. Global Infectious Disease Biomarker Testing Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 55. Global Infectious Disease Biomarker Testing Market Size Market Share Forecast by Application (2021-2026)
Table 56. Abacus Diagnostica Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 57. Abacus Diagnostica Infectious Disease Biomarker Testing Product Offered
Table 58. Abacus Diagnostica Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 59. Abacus Diagnostica Main Business
Table 60. Abacus Diagnostica Latest Developments
Table 61. ALPCO Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 62. ALPCO Infectious Disease Biomarker Testing Product Offered
Table 63. ALPCO Main Business
Table 64. ALPCO Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 65. ALPCO Latest Developments
Table 66. Abbott Laboratories Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 67. Abbott Laboratories Infectious Disease Biomarker Testing Product Offered
Table 68. Abbott Laboratories Main Business
Table 69. Abbott Laboratories Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 70. Abbott Laboratories Latest Developments
Table 71. Agilent Technologies Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 72. Agilent Technologies Infectious Disease Biomarker Testing Product Offered
Table 73. Agilent Technologies Main Business
Table 74. Agilent Technologies Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 75. Agilent Technologies Latest Developments
Table 76. Becton Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 77. Becton Infectious Disease Biomarker Testing Product Offered
Table 78. Becton Main Business
Table 79. Becton Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 80. Becton Latest Developments
Table 81. Dickinson and Company Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 82. Dickinson and Company Infectious Disease Biomarker Testing Product Offered
Table 83. Dickinson and Company Main Business
Table 84. Dickinson and Company Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 85. Dickinson and Company Latest Developments
Table 86. bioMérieux SA Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 87. bioMérieux SA Infectious Disease Biomarker Testing Product Offered
Table 88. bioMérieux SA Main Business
Table 89. bioMérieux SA Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 90. bioMérieux SA Latest Developments
Table 91. Bio-Rad Laboratories Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 92. Bio-Rad Laboratories Infectious Disease Biomarker Testing Product Offered
Table 93. Bio-Rad Laboratories Main Business
Table 94. Bio-Rad Laboratories Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 95. Bio-Rad Laboratories Latest Developments
Table 96. Danaher Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 97. Danaher Infectious Disease Biomarker Testing Product Offered
Table 98. Danaher Main Business
Table 99. Danaher Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 100. Danaher Latest Developments
Table 101. F. Hoffmann-La Roche Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 102. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Product Offered
Table 103. F. Hoffmann-La Roche Main Business
Table 104. F. Hoffmann-La Roche Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. F. Hoffmann-La Roche Latest Developments
Table 106. Hologic Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 107. Hologic Infectious Disease Biomarker Testing Product Offered
Table 108. Hologic Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 109. Hologic Main Business
Table 110. Hologic Latest Developments
Table 111. PerkinElmer Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 112. PerkinElmer Infectious Disease Biomarker Testing Product Offered
Table 113. PerkinElmer Main Business
Table 114. PerkinElmer Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 115. PerkinElmer Latest Developments
Table 116. Qiagen Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 117. Qiagen Infectious Disease Biomarker Testing Product Offered
Table 118. Qiagen Main Business
Table 119. Qiagen Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 120. Qiagen Latest Developments
Table 121. Quest Diagnostics Incorporated Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 122. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Product Offered
Table 123. Quest Diagnostics Incorporated Main Business
Table 124. Quest Diagnostics Incorporated Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 125. Quest Diagnostics Incorporated Latest Developments
Table 126. Siemens Healthineers Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 127. Siemens Healthineers Infectious Disease Biomarker Testing Product Offered
Table 128. Siemens Healthineers Main Business
Table 129. Siemens Healthineers Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 130. Siemens Healthineers Latest Developments
Table 131. Thermo Fisher Scientific Details, Company Type, Infectious Disease Biomarker Testing Area Served and Its Competitors
Table 132. Thermo Fisher Scientific Infectious Disease Biomarker Testing Product Offered
Table 133. Thermo Fisher Scientific Main Business
Table 134. Thermo Fisher Scientific Infectious Disease Biomarker Testing Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 135. Thermo Fisher Scientific Latest Developments
List of Figures
Figure 1. Infectious Disease Biomarker Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Disease Biomarker Testing Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Infectious Disease Biomarker Testing Market Size Market Share by Type in 2020
Figure 7. Infectious Disease Biomarker Testing in Hospitals and Clinics
Figure 8. Global Infectious Disease Biomarker Testing Market: Hospitals and Clinics (2016-2021) & ($ Millions)
Figure 9. Infectious Disease Biomarker Testing in Diagnostic Centers
Figure 10. Global Infectious Disease Biomarker Testing Market: Diagnostic Centers (2016-2021) & ($ Millions)
Figure 11. Infectious Disease Biomarker Testing in Academic Research Institutes
Figure 12. Global Infectious Disease Biomarker Testing Market: Academic Research Institutes (2016-2021) & ($ Millions)
Figure 13. Infectious Disease Biomarker Testing in Others
Figure 14. Global Infectious Disease Biomarker Testing Market: Others (2016-2021) & ($ Millions)
Figure 15. Global Infectious Disease Biomarker Testing Market Size Market Share by Application in 2020
Figure 16. Global Infectious Disease Biomarker Testing Revenue Market Share by Player in 2020
Figure 17. Global Infectious Disease Biomarker Testing Market Size Market Share by Regions (2016-2021)
Figure 18. Americas Infectious Disease Biomarker Testing Market Size 2016-2021 ($ Millions)
Figure 19. APAC Infectious Disease Biomarker Testing Market Size 2016-2021 ($ Millions)
Figure 20. Europe Infectious Disease Biomarker Testing Market Size 2016-2021 ($ Millions)
Figure 21. Middle East & Africa Infectious Disease Biomarker Testing Market Size 2016-2021 ($ Millions)
Figure 22. Americas Infectious Disease Biomarker Testing Market Size Market Share by Country in 2020
Figure 23. Americas Infectious Disease Biomarker Testing Market Size Market Share by Type in 2020
Figure 24. Americas Infectious Disease Biomarker Testing Market Size Market Share by Application in 2020
Figure 25. United States Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 26. Canada Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 27. Mexico Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 28. APAC Infectious Disease Biomarker Testing Market Size Market Share by Regions in 2020
Figure 29. APAC Infectious Disease Biomarker Testing Market Size Market Share by Type in 2020
Figure 30. APAC Infectious Disease Biomarker Testing Market Size Market Share by Application in 2020
Figure 31. China Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 32. Japan Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 33. Korea Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 34. Southeast Asia Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 35. India Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 36. Australia Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 37. Europe Infectious Disease Biomarker Testing Market Size Market Share by Country in 2020
Figure 38. Europe Infectious Disease Biomarker Testing Market Size Market Share by Type in 2020
Figure 39. Europe Infectious Disease Biomarker Testing Market Size Market Share by Application in 2020
Figure 40. Germany Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 41. France Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 42. UK Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 43. Italy Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 44. Russia Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 45. Middle East & Africa Infectious Disease Biomarker Testing Market Size Market Share by Region in 2020
Figure 46. Middle East & Africa Infectious Disease Biomarker Testing Market Size Market Share by Type in 2020
Figure 47. Middle East & Africa Infectious Disease Biomarker Testing Market Size Market Share by Application in 2020
Figure 48. Egypt Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 49. South Africa Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 50. Israel Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 51. Turkey Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 52. GCC Country Infectious Disease Biomarker Testing Market Size Growth 2016-2021 ($ Millions)
Figure 53. Americas Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 54. APAC Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 55. Europe Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 56. Middle East & Africa Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 57. United States Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 58. Canada Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 59. Mexico Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 60. Brazil Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 61. China Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 62. Japan Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 63. Korea Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 64. Southeast Asia Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 65. India Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 66. Australia Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 67. Germany Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 68. France Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 69. UK Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 70. Italy Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 71. Russia Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 72. Spain Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 73. Egypt Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 74. South Africa Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 75. Israel Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 76. Turkey Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
Figure 77. GCC Country Infectious Disease Biomarker Testing Market Size 2021-2026 ($ Millions)
